Cut Mix 150 — Trenbolone Acetate, Testosterone Propionate and Drostanolone Propionate by Dragon Pharma
Cut Mix 150 is Dragon Pharma's short-ester cutting blend at 150mg/ml, combining Trenbolone Acetate, Testosterone Propionate and Drostanolone Propionate in a single 10ml MCT oil vial. This is the fast-acting counterpart to Cut Long 300 — the same three-compound rationale (Tren/Test/Masteron) in short esters for faster onset, faster clearance and earlier PCT.
Also searched as: Cut Mix 150mg, Tren Ace Test Prop Masteron blend, cutting blend short ester, Cut Mix Dragon Pharma.
Why All Short Esters — The Synchronised Clearance Advantage
The choice to use Acetate and Propionate esters for all three compounds in Cut Mix 150 is deliberate and mechanistically significant — a point rarely explained properly in competitor content:
- All three compounds have approximately the same half-life (~2-3 days) — they rise together, stabilise together and clear together from a single EOD injection
- Synchronised clearance means PCT can begin just 3-5 days after the last injection — all three compounds reach sub-therapeutic levels simultaneously, allowing the SERM to work against all three compounds' suppression at once rather than waiting for the slowest ester to clear
- Side effect exit speed: if the cycle must be stopped — particularly relevant with Trenbolone — all three compounds including Trenbolone Acetate begin clearing within 4-6 days. Compare to Cut Long 300's Enanthate esters where meaningful blood levels persist for 3-4 weeks after stopping
- Shorter cycle feasibility: a 6-8 week Cut Mix 150 cycle produces meaningful results with enough time at stable levels — the short esters reach steady-state in approximately 10-15 days versus 5-6 weeks for Enanthate-based compounds
Ester Composition and Release Profile
| Component | Amount | Ester | Half-Life | Role |
|---|---|---|---|---|
| Trenbolone Acetate | ~50 mg/ml | Acetate | ~2–3 days | Primary anabolic — hardness, fat loss, strength |
| Testosterone Propionate | ~50 mg/ml | Propionate | ~2 days | Hormonal base — prevents low-test sides, supports libido |
| Drostanolone Propionate | ~50 mg/ml | Propionate | ~2–3 days | Hardness, internal AI activity, SHBG binding |
At 150mg/ml total (50mg of each per ml), a 1ml EOD injection delivers approximately 175mg/week of each compound — providing meaningful working doses of all three within a single small injection volume. This higher individual-compound weekly dose per ml compared to separate products is one of Cut Mix 150's practical advantages for users running EOD schedules.
Cut Mix 150 vs Cut Long 300 — The Core Decision
| Parameter | Cut Mix 150 (Short Esters) | Cut Long 300 (Enanthate) |
|---|---|---|
| Ester type | Acetate + Propionate (short) | All Enanthate (long) |
| Half-life | ~2–3 days | ~7–10 days |
| Injection frequency | Every other day | Twice weekly |
| Time to stable levels | ~10–15 days | ~35–50 days |
| Minimum practical cycle | 6–8 weeks | 10–14 weeks |
| PCT start after last injection | 3–5 days | 14–21 days |
| Side effect resolution if stopped | Within 1–2 weeks | 3–4 weeks |
| Concentration | 150 mg/ml (50mg each) | 300 mg/ml (100mg each) |
The choice is primarily about cycle length and flexibility. Cut Mix 150 is the appropriate choice when: the cycle is 6-10 weeks; faster side effect exit is valuable (particularly important given Trenbolone); earlier PCT is the priority; or the user is running their first combined Tren/Test/Masteron stack and wants the faster escape window. Cut Long 300 suits 10-14 week cycles where the injection frequency reduction of twice-weekly outweighs the slower clearance disadvantage.
Effects and Benefits
- Maximum muscle hardness and vascularity from the combined Trenbolone Acetate and Drostanolone Propionate action
- Significant fat loss support through Trenbolone's direct fat oxidation mechanism
- Maintained libido and hormonal function from the Testosterone Propionate component
- Drostanolone's internal AI activity reduces estrogen management demands from the Testosterone component
- Fastest onset of any Tren/Test/Masteron combination — stable levels reached within 2 weeks
- Earliest PCT window of any Tren/Test/Masteron combination — 3-5 days post last injection
Side Effects
- From Trenbolone Acetate: insomnia, night sweats, elevated prolactin (Cabergoline recommended), increased aggression
- From Testosterone Propionate: aromatisation partially managed by Drostanolone's intrinsic AI activity; Arimidex available if needed at higher doses
- Injection site discomfort — Propionate esters carry inherent PIP; EOD injection frequency compounds this requirement
- Suppression of natural testosterone — Post Cycle Therapy required; can begin 3-5 days after last injection
Dosage and Administration
| Experience Level | Dose per injection | Frequency | Weekly Total | Cycle Length |
|---|---|---|---|---|
| Advanced | 1 ml | Every other day | ~525 mg total (~175mg each compound) | 6–10 weeks |
| Advanced high-dose | 1.5–2 ml | Every other day | ~787–1050 mg total | 6–8 weeks |
Cut Mix 150 is not a beginner compound — the Trenbolone Acetate component requires prior Trenbolone experience. EOD injection is mandatory for stable blood levels given the short half-lives of all three compounds.
Building a Protocol Around Cut Mix 150
- Cut Mix 150 is self-contained — all three required cutting compounds are present in the blend
- Winstrol 10 or Anavar 10 as an oral addition for peak week hardness
- Cabergoline for prolactin management from the Trenbolone component
- Clomid or Nolvadex for PCT — starting 3-5 days after last injection
"Cut Mix 150 is the short-ester counterpart to Cut Long 300 — the same Trenbolone/Testosterone/Masteron trio in Acetate and Propionate esters for users who want faster onset, faster clearance and the earliest possible PCT window from this cutting combination."
Storage and Handling
Store Cut Mix 150 at room temperature, away from direct sunlight and heat. Use sterile technique for every draw — a fresh needle for drawing and a separate needle for injection is recommended.
